The Wise App Trial for Improving Health Outcomes in PLWH
The Wise App Trial for Improving Health Outcomes in PLWH
批准号:
10013220
负责人:
Rebecca Schnall
金额:
$39.25万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-30 至 2022-09-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Wise App Trial for Improving Health Outcomes in PLWH
Human Immunodeficiency virus (HIV) continues to affect 1.2 million Americans. Achieving viral suppression
through adherence to antiretroviral (ART) therapy is a critical determinant of successful transmission
prevention and long-term outcomes in HIV-infected patients. However only about 25% of persons living with
HIV (PLWH) in the US are virally suppressed, demonstrating the need for effective interventions that enhance
ART adherence. mHealth is a tool that has proven useful in supporting behavior change, but most mHealth
tools for PLWH have not been well-developed or evaluated. Given the dearth of useful and likeable apps, the
need for improving medication adherence in PLWH, and the great promise of mHealth, we propose to build
and test a user-centered smartphone app linked to a smart pill box targeting ART adherence in PLWH. Self-
report of medication adherence is often criticized since it typically overestimated adherence especially in
unmasked trials. Current adherence assessments, such as patient recall, pill counts and pharmacy refill data,
typically detect missed doses long after they occur. Our study will use real-time, wireless monitoring strategies
via the Wisepill dispenser, for measuring ART adherence. This will overcome this often cited limitation and
provide novel opportunities to proactively prevent virologic rebound and treatment failure. Guided by Fogg's
Functional Triad for persuasive technology and building on our earlier user-centered design work, the
proposed intervention has the potential to not only improve ART adherence in PLWH, but also have a
sustainable public health impact. The aims of our study are to: (1) Build a functional app for HIV self-
management linked to a smart pill box (Wise App) for PLWH and assess its usability; (2) Evaluate the impact
of the Wise App on medication adherence in underserved PLWH; and (3) Assess PLWH perceptions of the
predisposing, enabling, and reinforcing factors for Wise App use through theoretically-guided focus group
sessions. The proposed study extends our preliminary work that employed user-centered design methods to
identify the content, features, functionalities, and interface of a mobile app to improve health outcomes in
PLWH. The user-centered design app we will build will then be linked to a smart pill box so that PLWH can
receive feedback on their adherence behaviors. Our study intervention, the Wise App, is relevant, timely, of
public health import, and supported by substantial preliminary work. The proposed trial is significant in
representing a principled and systematic effort to build, and test the efficacy of a smartphone intervention for
ART adherence in PLWH in the US. Importantly, this work has broader implications and will improve our
understanding of how to support patients' medication adherence, regardless of treatment target.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissemination of the WiseApp for Improving Health Outcomes Across Settings
-
批准号:10490284
-
项目类别:
-
资助金额:$39.41万
-
财政年份:2021
-
负责人:Rebecca Schnall
-
依托单位:
Dissemination of the WiseApp for Improving Health Outcomes Across Settings
-
批准号:10685304
-
项目类别:
-
资助金额:$38.53万
-
财政年份:2021
-
负责人:Rebecca Schnall
-
依托单位:
mChoice: Improving PrEP Uptake and Adherence among Minority MSM through Tailored Provider Training and Adherence Assistance in Two High Priority Settings
-
批准号:10324998
-
项目类别:
-
资助金额:$103.92万
-
财政年份:2021
-
负责人:Rebecca Schnall
-
依托单位:
mChoice: Improving PrEP Uptake and Adherence among Minority MSM through Tailored Provider Training and Adherence Assistance in Two High Priority Settings
-
批准号:10488047
-
项目类别:
-
资助金额:$103.99万
-
财政年份:2021
-
负责人:Rebecca Schnall
-
依托单位:
mChoice: Improving PrEP Uptake and Adherence among Minority MSM through Tailored Provider Training and Adherence Assistance in Two High Priority Settings
-
批准号:10663097
-
项目类别:
-
资助金额:$103.74万
-
财政年份:2021
-
负责人:Rebecca Schnall
-
依托单位:
Dissemination of the WiseApp for Improving Health Outcomes Across Settings
-
批准号:10290733
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2021
-
负责人:Rebecca Schnall
-
依托单位:
Mentoring and Research in Self-Management for Health Promotion and Disease Prevention
-
批准号:10380063
-
项目类别:
-
资助金额:$4.29万
-
财政年份:2019
-
负责人:Rebecca Schnall
-
依托单位:
Mentoring and Research in Self-Management for Health Promotion and Disease Prevention
-
批准号:9917843
-
项目类别:
-
资助金额:$11.45万
-
财政年份:2019
-
负责人:Rebecca Schnall
-
依托单位:
Use of mHealth Technology for Supporting Symptom Management in Underserved Persons Living with HIV
-
批准号:8902295
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2015
-
负责人:Rebecca Schnall
-
依托单位:
Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms
-
批准号:9111067
-
项目类别:
-
资助金额:$43.99万
-
财政年份:2015
-
负责人:Rebecca Schnall
-
依托单位:
Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms
-
批准号:9269103
-
项目类别:
-
资助金额:$47.42万
-
财政年份:2015
-
负责人:Rebecca Schnall
-
依托单位:
Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms
-
批准号:9235590
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2015
-
负责人:Rebecca Schnall
-
依托单位:
Informing the Development of Mobile Apps for HIV Prevention, Treatment and Care
-
批准号:8683354
-
项目类别:
-
资助金额:$5.73万
-
财政年份:2012
-
负责人:Rebecca Schnall
-
依托单位:
Informing the Development of Mobile Apps for HIV Prevention, Treatment and Care
-
批准号:8409728
-
项目类别:
-
资助金额:$24.64万
-
财政年份:2012
-
负责人:Rebecca Schnall
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于单细胞和空间转录组分析APP-CD74在衰老泪腺中介导免疫微环境紊乱的机制研究
-
批准号:2026JJ50085
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王万鹏
-
依托单位:
基于GPX4/ACSL4铁死亡通路的 APP 基因突变调控 Aβ 代谢异常在阿尔茨海默病中的作用机制研究
-
批准号:JCZRLH202600691
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
DDAH2在小胶质细胞中调控APP蛋白代谢的新机制及其在阿尔兹海默症中的作用
-
批准号:2026JJ80535
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李俊杰
-
依托单位:
APP细胞间信号介导癌症干细胞与肿瘤细胞的互作驱动肾癌干性特征和肿瘤发生发展的机制研究
-
批准号:JCZRLH202500082
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
电针心包经穴调控PI3K/AKT/GLT-1轴改善APP/PS1双转基因小鼠学习记忆障碍的机制研究
-
批准号:2025JJ60638
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:柯超
-
依托单位:
APP-中医康护现代化技术应用对脑卒中患者健康管理模式的影响效果观察
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:焦迦鸣
-
依托单位:
基于Sirt1介导FoxO3a去乙酰化调控线粒体分裂/融合平衡探讨电针心经穴改善APP/PS1小鼠认知功能障碍的研究
-
批准号:2025JJ60635
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:曹洋
-
依托单位:
OPA1复合杂合突变调控β淀粉样前体蛋白APP导致Behrsyndrome发生的作用机制和神经功能重建研究
-
批准号:QN25H090051
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王呈辉
-
依托单位:
运动皮层-背外侧纹状体神经环路谷氨酸能神经元介导APP/PS1小鼠早期运动技能学习障碍的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:江锦祥
-
依托单位:
乳酸对3月龄APP/PS1小鼠神经元突触丢失的改善作用及分子机制研
究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:张茂
-
依托单位: